Our studies have established a mouse model for endogenous glucocorticoid excess that is due to a gain-of-function mutation in the promoter region of the Crh gene (Crh-120) (Figure 3) and thus differs in cause from typical ACTH-dependent CS. Here, POMC is linked to Cowden syndrome 1.